Gene Query: SLC30A7

Dataset Description Geneva Score
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 37.64
Region-specific Innate Antiviral Responses of the Human Epididymis 37.63
Gene expression analysis of dengue-infected cells 36.76
Triple vectors expand AAV transfer capacity in the retina 36.3
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 25.52
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 23.87
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 23.87
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 22.76
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 22.14
HNF1 regulates critical functions of the human epididymis epithelium. 21.34
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 21.34
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 20.74
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 20.6
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 20.31
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 19.37
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 19.06
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 17.93
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 16.02
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 15.91
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 15.56
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 15.49
Transcriptional responses of human insulinoma cells to acute cytokine exposure 15.27
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 15.27
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 15.03
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 14.77
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 14.15
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 14.15
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 14.01
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 13.82
Role for citron kinase in prostate cancer growth 13.0
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 12.97
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 12.97
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 12.94
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 12.89
R430: A potent inbibitor of DNA and RNA viruses 12.84
IRF2 is a master regulator of human keratinocyte stem cell fate 12.84
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 12.84
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 12.73
AR-independent prostate cancer is sustained through FGF signaling 12.66
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 12.52
Hijacking of stress response machinery by oncogenes in acute leukaemia 12.52
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 12.41
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 12.32
Ribosomal footprinting of MDA-Parental and MDA-LM2 12.2
mRNA expression profile of Lymphocytes 12.11
Aneuploidy triggers an immune response 11.96
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 11.69
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 11.69
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 11.44
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 11.44
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 11.4
TGF-β regulation of miRNA expression in pancreatic cancer 11.33
HNRNPL and its RNA Targets in Prostate Cancer 11.31
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 11.31
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 11.24
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 11.24
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 11.19
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 11.18
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 11.03
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 11.02
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 10.98
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 10.91
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 10.87
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 10.83
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 10.83
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 10.59
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 10.59
Differential gene expression of human melanoma cells [RNA-seq] 10.59
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 10.59
Human cell line and subcutaneous tumor 10.5
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 10.5
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 10.5
Ribosomal footprinting of CN34-Parental and CN34-LM1a 10.46
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 10.32
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 10.27
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 9.92
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 9.91
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 9.69
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 9.57
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 9.43
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 9.41
Impact of dieldrin on transcription in Jurkat T cells 9.39
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 9.25
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 9.19
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 9.16
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 9.16
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 8.99
Gene expression profiling of human and murine in vitro muscle differentiation 8.88
Integrating single-cell transcriptomic data across different conditions, technologies, and species 8.85
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 8.8
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 8.69
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 8.63
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 8.63
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 8.52
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 8.38
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 8.38
High-throughput sequencing of PROMPT-enriched samples. 8.37
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 8.37
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 8.23
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 8.23
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 8.12
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 8.12
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 8.12
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 8.09
Electronic cigarettes 8.03
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 8.0
Trans-differentiation of human adult peripheral blood T cells into neurons 7.99
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 7.98
DART-seq: an antibody-free method for global m6A detection 7.87
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 7.84
Systematic discovery of endogenous human ribonucleoprotein complexes 7.73
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 7.68
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 7.55
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 7.49
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 7.49
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 7.47
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 7.47
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 7.47
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 7.46
The Genomic Landscape of Atypical Fibroxanthoma 7.44
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 7.44
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 7.4
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 7.36
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 7.34
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 7.34
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 7.33
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 7.26
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 7.17
Identification of HOXB13 target genes responsive to BET inhibitors 7.16
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 7.12
RNA Seq of HMVEC under hypoxia 7.08
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 7.08
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 7.06
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 6.97
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 6.91
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 6.89
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 6.89
PNET animal model: new insights (II) 6.87
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 6.83
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 6.82
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 6.78
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 6.77
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 6.73
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 6.68
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 6.67
Mitochondrial dsRNA triggers antiviral signalling in humans 6.63
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 6.61
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 6.61
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 6.6
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 6.55
Gene expression changes after LOC550643 silencing 6.54
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 6.54
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 6.52
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 6.52
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 6.5
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 6.5
Regulation of poly(A) tail and translation during the somatic cell cycle 6.5
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 6.42
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 6.42
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 6.4
Genes significantly down or Up-regulated upon RNF219 knockdown 6.36
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 6.35
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 6.29
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 6.29
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 6.29
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 6.28
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 6.28
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 6.28
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 6.26
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 6.25
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 6.23
An RNA-centric dissection of host complexes controlling flavivirus infection 6.23
SLIGRL-induced gene expression changes in NHEK cells 6.2
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 6.17
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 6.16
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 6.13
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 6.12
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 6.12
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 6.09
Mapping interactions for the TNIP2 hub protein 6.08
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 6.07
Paxillin regulates genomic networks in prostate cancer [PC3] 6.06
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 6.01
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 6.01
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 5.98
Transcriptome analysis upon C6orf203 silencing 5.97
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 5.88
Transcriptome analysis in Neobractatin treated cells 5.86
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 5.85
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 5.85
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 5.85
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 5.85
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 5.82
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 5.81
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 5.72
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 5.71
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 5.71
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 5.69
Genome wide miR-191 target profile determined by RIP and gene expression profiling 5.69
Role of microRNAs in the interaction between Salmonella and the host cell 5.67
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  5.66
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 5.66
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 5.64
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 5.63
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 5.55
The conserved transcriptional landscapes in human spermatogenesis 5.55
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 5.54
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 5.54
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 5.54
RNA-sequencing of human liver tissue 5.53
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 5.51
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 5.5
Genome-wide analysis of Dengue virus 2 infected cells 5.46
Regulation of Lipids is Central to Replicative Senescence 5.43
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 5.41
Molecular Mechanisms of Endothelial Hyperpermeability 5.38
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 5.35
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 5.34
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 5.3
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 5.29
Tracking distinct RNA populations using efficient and reversible covalent chemistry 5.27
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 5.26
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 5.22
Effect of BB608 on Gene Expression in HNSCC Cell Line 5.22
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 5.18
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 5.17
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 5.17
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 5.17
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 5.17
Paxillin regulates genomic networks in prostate cancer [C4-2] 5.15
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 5.15
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 5.13
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 5.1
Differential Protein Occupancy Profiling of the mRNA Transcriptome 5.09
Epigenetic reprogramming of melanoma cells by vitamin C treatment 5.01
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 4.92
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 4.92
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 4.91
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 4.89
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 4.88
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 4.86
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 4.85
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 4.83
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 4.82
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 4.81
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 4.81
Gene expression profiling of leukemia cells following asparagine depletion 4.8
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 4.79
mRNA recovered upon RNF219 IP. [RNA-IP] 4.77
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 4.75
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 4.75
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 4.74
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 4.74
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 4.68
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 4.68
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 4.68
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 4.67
m6A-dependent regulation of messenger RNA stability 4.66
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 4.65
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 4.58
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 4.58
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 4.55
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 4.54
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 4.52
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 4.51
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 4.49
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 4.49
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 4.48
Effect of from Human Umbilical Vein Endothelial Cells 4.48
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 4.46
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 4.45
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 4.43
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 4.4
RNA seq comparison between scrambled and shGRP78 cells 4.37
Transcriptome landscape of HeLa response upon triamcinolone acetonide 4.34
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 4.33
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 4.31
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 4.3
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 4.27
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 4.26
Hepatitis C virus functionally sequesters miR-122 4.25
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 4.25
The effect of Abl kinases on non-small cell carcinoma global transcriptome 4.24
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 4.2
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 4.2
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 4.15
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 4.14
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 4.11
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 4.02
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 4.02
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 4.0
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 3.98
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 3.98
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 3.97
ARS2 is a general suppressor of pervasive transcription [RNAseq] 3.93
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 3.91
Oncogenic roles of ARID5B in T-ALL 3.91
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 3.86
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 3.77
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 3.67
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 3.67
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 3.65
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 3.64
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 3.56
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 3.56
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 3.54
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 3.53
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 3.53
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 3.52
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 3.51
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 3.49
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 3.49
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 3.49
Sensing self and nonself circular RNAs 3.48
Transcriptomic analysis of human tonsillar TFH subsets 3.47
Real-time observation of light-controlled transcription in living cells 3.46
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 3.36
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 3.36
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 3.34
Splicing and epigenetic factors jointly regulate epidermal differentiation 3.21
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 3.21
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 3.2
RNA expression analysis upon JMJD1C depletion 3.2
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 3.17
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 3.14
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 3.13
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.12
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 3.04
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 3.04
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 3.04
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 3.02
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 3.02
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.99
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 2.93
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 2.9
Human Treg IL-12 stimulation 2.85
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 2.84
Downregulation of LATS kinases alters p53 to promote cell migration 2.81
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 2.79
Argonaute proteins couple chromatin silencing to alternative splicing 2.78
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 2.78
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 2.75
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 2.73
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 2.71
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 2.7
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 2.7
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 2.69
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 2.69
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 2.66
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 2.63
IL-33 activates tumor stroma to promote intestinal polyposis 2.61
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 2.58
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 2.56
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 2.56
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 2.56
METTL3 and WTAP 2.54
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 2.53
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 2.47
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 2.47
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 2.44
MicroRNA-125a-5p overexpression in human macrophages 2.43
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 2.4
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 2.4
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 2.39
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 2.39
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 2.35
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 2.32
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 2.28
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.19
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 2.17
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 2.14
Epigenomic conservation of transposable element silencing [RNA-seq] 2.12
Epigenomic conservation of transposable element silencing 2.12
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 2.12
RNA-seq of MDA-MB-231 cells with TET1 knockout 2.06
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.05
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 2.03
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 2.02
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 2.0
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 1.99
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 1.99
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 1.96
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 1.96
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 1.95
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 1.94
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 1.94
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 1.91
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 1.91
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 1.9
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 1.9
Transcriptome profiling of 5 human adenocarcinoma cell lines 1.88
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.85
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 1.81
RNA-seq data 1.8
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 1.78
Identification of a LIF-responsive replication-competent human β cell 1.72
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 1.69
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.66
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 1.62
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 1.61
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 1.59
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 1.57
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 1.56
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 1.55
STX4 Over-Expression in Human islets 1.54
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 1.53
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 1.49
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 1.46
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 1.39
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 1.33
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 1.33
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 1.33
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.23
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 1.21
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 1.21
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 1.21
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 1.2
Primate-specific gene TMEM14B promotes cortical expansion and folding 1.19
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 1.19
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 1.17
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 1.16
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 1.16
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 1.16
Regulation of hypoxia-inducible factor activity by ZMYND8 1.13
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 1.08
Human Treg IFNg/IL-10 subpopulations 1.0
Transcriptome analysis of SKI knock-out in HL60 cells 0.96
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 0.96
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 0.96
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.95
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.95
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 0.93
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.93
Aging-associated patterns in the expression of human endogenous retroviruses 0.93
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 0.93
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 0.93
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 0.93
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 0.91
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.91
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 0.9
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.89
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 0.86
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 0.86
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.85
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.85
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.83
MAIT cell RNA sequencing 0.81
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.77
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.77
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 0.75
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 0.75
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.73
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.73
Microprocessor mediates transcription termination in long noncoding microRNA genes 0.71
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 0.71
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.65
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.59
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.59
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.56
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.56
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.52
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.51
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 0.49
RNA-seq analysis upon ARID1B overexpression 0.48
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.43
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 0.4
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 0.36
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 0.36
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 0.36
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.36
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.35
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.35
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.32
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.32
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 0.32
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.31
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.3
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.29
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 0.28
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.27
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.27
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.25
A code of mono-phosphorylation modulates the function of RB. 0.24
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.22
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.22
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 0.2
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 0.2
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.18
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 0.08
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 0.08
The role of the Calcium-Sensing receptor in colorectal cancer 0.06
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 0.05
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.04
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.03
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.03
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.02
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 0.02
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 0.02
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.01
High-resolution comparative analysis of great ape genomes 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation